ARCHIVES

Iniparib Doesn’t Meet Survival, PFS Endpoints In Phase III Trial in Triple-Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

Children, Parents Differ In Decisionmaking On Cancer Treatment, Survivor Study Finds

July 29, 2005

VTP Implementing 95% Of Ad Hoc Panel Suggestions

May 10, 1985

Merger Of Centers, Control Programs An Option, Upton Says; ACS To Fund New Prevention Centers

February 2, 1979

Three NCAB Members Say They Cannot Offer “Strong Endorsement” Of P-4 Trial.

June 15, 2007

Waxman Introduces NIH Reauthorization, Kennedy To Follow

April 26, 1991

Black Physicians, Community Group To work With NCI

April 21, 1989